Differential expression analysis based on PAM50 classification identified a larger number of differentially expressed mRNAs compared to classification based on hormone receptor and HER2 status, while largest difference was seen when comparing LumA and basal BC. This evidence concerns the gene NR4A1 and breast cancer.